U.S., Jan. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07361289) titled 'A Study to Assess the Real-World Effectiveness of Mavacamten in Adult Patients With Obstructive Hypertrophic Cardiomyopathy in China' on Jan. 14.
Brief Summary: The purpose of this study is to assess the effectiveness of mavacamten treatment in Chinese adults with symptomatic obstructive hypertrophic cardiomyopathy (HCM) in real-world clinical practice
Study Start Date: Jan. 16
Study Type: OBSERVATIONAL
Condition:
Hypertrophic Cardiomyopathy
Intervention:
DRUG: Mavacamten
According to the product label
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Bristol-Myers Squibb
Published by HT Digital Content Services with permiss...